new article in scientific american, but no mention of lympro (or for that matter many other tests we've become aware of over the last year): http://www.scientificamerican.com/article/alz...SA_Twitter

the competitors seem to be multiplying, but as this article notes, they're all inching forward, and many are years from market, clinically unproven etc.

If we can get our product taken up early, get the name out, get more data, I hope our test combined with the Gtown assays released in a new amarantus diagnostic package will compete or outperform these tests before they get to market.

please note several of the skin tests looking for Tau have even if they're accurate are likely useless for early diagnosis.